Freudenberg Medical, a leading global partner in the design, development, and manufacturing of medical devices and biopharma solutions, has announced a strategic leadership transition. Effective January 1, 2025, Michael McGee has stepped into the role of Chief Executive Officer, succeeding Dr. Mark Ostwald, who has transitioned to another leadership position within the Freudenberg Group.
McGee joined Freudenberg Medical as Chief Operating Officer in 2022, bringing with him more than three decades of experience in the medical device sector. His promotion to CEO reflects the company’s commitment to fostering leadership continuity and aligning with its core values and long-term strategic goals.
As CEO, McGee is focused on strengthening the company’s customer-centric approach by driving investments in cutting-edge technologies, skilled talent, and optimized processes. He expressed his appreciation for the company’s foundational values and the expertise of its global team, highlighting their collective ability to advance healthcare. McGee reiterated the company’s dedication to being a trusted strategic partner, ensuring customer success remains a top priority.
Dr. Mohsen Sohi, CEO of the Freudenberg Group and Speaker of the Management Board, expressed confidence in McGee’s leadership. He noted that McGee has already demonstrated his capability to deliver impactful results, and the Board of Management is optimistic that under his direction, Freudenberg Medical will continue to achieve growth, innovation, and long-term success.
Dr. Mark Ostwald, who served Freudenberg Medical for 16 years in various leadership roles, leaves behind an impressive legacy. During his tenure as CEO, the company doubled its annual revenue, expanded its global manufacturing capabilities by one-third, and successfully integrated three Joint Ventures. Dr. Sohi commended Ostwald’s strategic vision and dedication, emphasizing how his leadership elevated Freudenberg Medical’s reputation as a trusted partner in the medical device and pharmaceutical industries.
Reflecting on his time at the company, Ostwald expressed gratitude for the opportunity to lead and contribute to its success. He voiced confidence in McGee’s ability to carry the company forward, praising his commitment to the company’s strategy, values, and mission of delivering high-quality products to improve patient outcomes. Ostwald emphasized that McGee is well-positioned to lead Freudenberg Medical to its next phase of growth and success.
With McGee at the helm, Freudenberg Medical is poised to build on its strong foundation and drive innovation in the medical and biopharma sectors, ensuring its continued role as a trusted partner in advancing healthcare.
Have you read?
Best countries for hiring freelancers.
Highest Paid Big Pharma CEOs And Top Executives.
Best Websites For CEOs, business leaders, and high-net-worth individuals.
Best Executive Search Firms And Consultants in America.
Revealed: Most Powerful Women In The World.
Bring the best of the CEOWORLD magazine's global journalism to audiences in the United States and around the world. - Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2025 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
